Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene
Open Access
- 13 July 2010
- journal article
- Published by Springer Nature in Molecular Cancer
- Vol. 9 (1), 190
- https://doi.org/10.1186/1476-4598-9-190
Abstract
Background: High frequency of loss of heterozygosity (LOH) was found at D7S486 in primary gastric cancer (GC). And we found a high frequency of LOH region on 7q31 in primary GC from China, and identified D7S486 to be the most frequent LOH locus. This study was aimed to determine what genes were affected by the LOH and served as tumor suppressor genes (TSGs) in this region. Here, a high-throughput single nucleotide polymorphisms (SNPs) microarray fabricated in-house was used to analyze the LOH status around D7S486 on 7q31 in 75 patients with primary GC. Western blot, immunohistochemistry, and RT-PCR were used to assess the protein and mRNA expression of TESTIN (TES) in 50 and 140 primary GC samples, respectively. MTS assay was used to investigate the effect of TES overexpression on the proliferation of GC cell lines. Mutation and methylation analysis were performed to explore possible mechanisms of TES inactivation in GC.Results: LOH analysis discovered five candidate genes (ST7,FOXP2,MDFIC,TESandCAV1) whose frequencies of LOH were higher than 30%. However, onlyTESshowed the potential to be a TSG associated with GC. Among 140 pairs of GC samples, decreasedTESmRNA level was found in 96 (68.6%) tumor tissues when compared with matched non-tumor tissues (p< 0.001). Also, reduced TES protein level was detected in 36 (72.0%) of all 50 tumor tissues by Western blot (p= 0.001). In addition, immunohistochemical staining result was in agreement with that of RT-PCR and Western blot. Down regulation of TES was shown to be correlated with tumor differentiation (p= 0.035) and prognosis (p= 0.035, log-rank test). Its overexpression inhibited the growth of three GC cell lines. Hypermethylation ofTESpromoter was a frequent event in primary GC and GC cell lines. However, no specific gene mutation was observed in the coding region of theTESgene.Conclusions: Collectively, all results support the role ofTESas a TSG in gastric carcinogenesis and thatTESis inactivated primarily by LOH and CpG island methylation.Keywords
This publication has 27 references indexed in Scilit:
- Caveolin-1 immuno-expression in human gastric cancer: histopathogenetic hypothesesVirchows Archiv, 2008
- Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinomaCancer Letters, 2008
- AccuTyping: new algorithms for automated analysis of data from high-throughput genotyping with oligonucleotide microarraysNucleic Acids Research, 2006
- Loss of heterozygosity analysis of a candidate gastric carcinoma tumor suppressor locus at 7q31Cancer Genetics and Cytogenetics, 2006
- A genotyping system capable of simultaneously analyzing >1000 single nucleotide polymorphisms in a haploid genomeGenome Research, 2005
- A simple method for fixation and microdissection of frozen fresh tissue sections for molecular cytogenetic analysis of cancersBiotechnic & Histochemistry, 2005
- Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor geneInternational Journal of Cancer, 2004
- The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain proteinOncogene, 2001
- Characterization of the Human TESTIN Gene Localized in the FRA7G Region at 7q31.2Genomics, 2000
- Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav‐1, ‐2, and ‐3)FEBS Letters, 1998